| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | Australia | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | United Kingdom | 2 | |
| #6 | United States | 2 | |
| #7 | Brazil | 1 | |
| #8 | China | 1 | |
| #9 | Mexico | 1 | |
| #10 | Norway | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Fong Benson M | 7 |
| #2 | Santel Donald J | 6 |
| #3 | Ruegg Curtis | 5 |
| #4 | Cornett Glen V | 4 |
| #5 | Cornett Glenn V | 3 |
| #6 | Blair Julian A | 3 |
| #7 | Fong Benson | 2 |
| #8 | N N | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP1951253A2 | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension | |
| EP1663396A2 | Iloprost in combination therapies for the treatment of pulmonary arterial hypertension | |
| CA2537180A1 | Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome | |
| GB0603059D0 | Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome |